by Sonya Goins, Mayo Clinic News Network Credit: Pixabay/CC0 Public Domain Uterine fibroids are the leading cause of women undergoing hysterectomies, leaving them unable to bear children. Fibroids often are diagnosed in women between 20 and 40. They can cause heavy menstrual bleeding, pain and infertility. Dr. Michelle Louie, a Mayo Clinic gynecologic surgeon and...
Tag: <span>uterine fibroids</span>
Post
New study using human fibroid cells supports use of green tea compound as treatment for uterine fibroids
JOHNS HOPKINS MEDICINE In a pre-clinical, proof-of-concept study from Johns Hopkins Medicine, researchers found that epigallocatechin gallate (EGCG), a green tea compound with powerful antioxidant properties, could be promising for both treating and preventing uterine fibroids. Results of the study, first posted online May 25 in Scientific Reports, add to growing evidence that EGCG may reduce fibroid cell...
Post
Drug trial shows promise for easing uterine fibroids
by Isabella Backman, Yale University A medical illustration depicting uterine fibroids. Credit: BruceBlaus/Wikimedia Commons, CC BY-SA About three quarters of women will experience uterine fibroids before they reach the age of 50. With a range of often debilitating symptoms including excessive menstrual bleeding, they are the most common reason women undergo hysterectomies. And there is a lack...
Post
Study discovers safe, effective oral treatment for uterine fibroids
by University of Chicago Medical Center Credit: CC0 Public Domain Uterine fibroids are a common cause of heavy menstrual bleeding and pain in women of reproductive age, especially among women of color. An estimated $34 billion in healthcare costs are associated with uterine fibroids in the United States alone each year, yet there are few treatment...
Post
Uterine fibroids can take a heavy emotional toll on women, study shows
by Marisol Martinez, Johns Hopkins University Credit: Pixabay/CC0 Public Domain In a comprehensive review of 57 research studies looking at the quality of life of women with uterine fibroids compared with that of people with other chronic diseases, Johns Hopkins Medicine researchers found that the psychological and social burden of the condition is comparable with those...
Post
A novel pill to treat bleeding from uterine fibroids aims for FDA approval
by Marie McCullough A new drug called elagolix cut blood loss by half over six months in the overwhelming majority of women who participated in two clinical trialspublished Wednesday in the New England Journal of Medicine. Elagolix, being developed by AbbVie, was approved by the U.S. Food and Drug Administration in 2018 under the brand...